At the news
? BEARISHIMPACT 8/10 8-K filed Apr 27, 2026 at 16:58 ET
InMed Pharmaceuticals amended preferred investment options (warrants) held by Sabby and H.C. Wainwright affiliates, reducing the exercise price from as high as $82.50 down to $0.80 per share. This makes the warrants deeply in-the-money relative to the current stock price (implied by the $2M market cap), enabling the holders to immediately purchase up to 2,304,714 common shares, more than doubling the outstanding shares and severely diluting existing shareholders.
- Sabby warrants amended to exercise price of $0.80 (was $2.436); Sabby can buy up to 2,151,478 shares.
- Wainwright warrants amended to exercise price of $0.80 (were as high as $82.50); Wainwright can buy up to 153,236 shares.
- Total potential new shares: 2,304,714 (excluding any other adjustments).
- Company market cap is $2M; the amendments enable massive dilution relative to current float.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access